About
An Australian medtech company at the forefront of precision diagnostics with three NEW first-in-class tests driven by the Promarker platform technology. Promarker®D is a predictive test for chronic kidney disease in type 2 diabetes which identifies patients at risk - whereas traditional tests (eGFR, ACR) indicate damage. Promarker®Eso a blood test for patients with GORD to rule out (99.99% NPV) the presence of esophageal cancer instead of endoscopy. Promarker®Endo a blood test identifies all stages of endometriosis with high accuracy (sensitivity and specificity up to 98%).